OpenAlex
PricingAboutJobs
Log inGet started
Work

Alzheimer's disease drug discovery: in vivo screening using Caenorhabditis elegans as a model for β-amyloid peptide-induced toxicity

HTML

Year: 2012
Type: review
Source: Drug Discovery Today Technologies
DOI: 10.1016/j.ddtec.2012.02.002
Authors: A.L. Lublin, C.D. Link
Institutions: Icahn School of Medicine at Mount Sinai, University of Colorado Boulder
Language: English

Topic: Alzheimer's disease research and treatments
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Keywords: Alzheimer's disease, drug discovery, Caenorhabditis elegans, beta-amyloid peptide, amyloid toxicity, in vivo screening, high-throughput screening, tau pathology, RNA interference, neurodegeneration model
SDG: Good health and well-being

Open Access status: green

Funder: National Institute on Aging
Award: Transgenic C. elegans as Amyloid Disease Model
OpenAlex ID: W1965500084
FWCI: 0.473
Cites: 35
Cited by: 140
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security